Back to Journals » Biologics: Targets and Therapy » Volume 15 » default

Biologics: Targets and Therapy


Archive: Volume 15, 2021

Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target

Chekol Abebe E, Mengie Ayele T, Tilahun Muche Z, Asmamaw Dejenie T

Biologics: Targets and Therapy 2021, 15:143-152

Published Date: 6 May 2021

Biological Therapies in Children and Adolescents with Severe Uncontrolled Asthma: A Practical Review

Votto M, De Filippo M, Licari A, Marseglia A, De Amici M, Marseglia GL

Biologics: Targets and Therapy 2021, 15:133-142

Published Date: 5 May 2021

Baculoviruses in Gene Therapy and Personalized Medicine

Schaly S, Ghebretatios M, Prakash S

Biologics: Targets and Therapy 2021, 15:115-132

Published Date: 28 April 2021

Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy

Hawkins ER, D'Souza RR, Klampatsa A

Biologics: Targets and Therapy 2021, 15:95-105

Published Date: 14 April 2021

Virus Neutralization by Human Intravenous Immunoglobulin Against Influenza Virus Subtypes A/H5 and A/H7

Kubota-Koketsu R, Yunoki M, Okuno Y, Ikuta K

Biologics: Targets and Therapy 2021, 15:87-94

Published Date: 13 April 2021

Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon

O'Donnell KL, Marzi A

Biologics: Targets and Therapy 2021, 15:79-86

Published Date: 18 March 2021

Glomerulonephritis in Two Patients with SpA Treated with TNF-α Blockers and a Review of the Literature

Bounia CA, Theodoropoulou EN, Liossis SNC

Biologics: Targets and Therapy 2021, 15:61-66

Published Date: 17 March 2021

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis

Mohammadi R, Aryan A, Omrani MD, Ghaderian SMH, Fazeli Z

Biologics: Targets and Therapy 2021, 15:53-59

Published Date: 2 March 2021

Biologic Treatments of Psoriasis: An Update for the Clinician

Brownstone ND, Hong J, Mosca M, Hadeler E, Liao W, Bhutani T, Koo J

Biologics: Targets and Therapy 2021, 15:39-51

Published Date: 16 February 2021

Convalescent Plasma for the Treatment of Severe COVID-19

Franchini M, Liumbruno GM

Biologics: Targets and Therapy 2021, 15:31-38

Published Date: 4 February 2021

Biologic Therapies for Giant Cell Arteritis

Harrington R, Al Nokhatha SA, Conway R

Biologics: Targets and Therapy 2021, 15:17-29

Published Date: 6 January 2021

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab

Fitzgerald T, Melsheimer R, Lafeuille MH, Lefebvre P, Morrison L, Woodruff K, Lin I, Emond B

Biologics: Targets and Therapy 2021, 15:1-15

Published Date: 6 January 2021